Varaico: Literature-Extracted Genetic Variants

Gene:CHCHD10
Variant:p.R15L
Back to variants list

CHCHD10

NM_213720.3:p.R15L

Associated Papers

A mouse model of CHCHD10 p.R15L familial ALS presents mild, age-related motor neuron degeneration without protein instability or mitochondrial dysfunction.

Park J et al.

Biorxiv : the Preprint Server for Biology, 2025

Investigation of mitochondrial phenotypes in motor neurons derived by direct conversion of fibroblasts from familial ALS subjects.

Woo E et al.

Cell Death & Disease, 2025

Clinical, neuropathological, and biochemical characterization of ALS in a large CHCHD10 R15L family.

Kwan JY et al.

Medrxiv : the Preprint Server for Health Sciences, 2025

Amyloid fibril structures link CHCHD10 and CHCHD2 to neurodegeneration.

Lv G et al.

Nature Communications, 2025

Impacts of pathogenic mutations on the structures of the CHCHD10 monomer: An AlphaFold3 study linked to the generation of conformational ensembles.

Akkum FI et al.

International Journal of Biological Macromolecules, 2025

Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism.

Harjuhaahto S et al.

Acta Neuropathologica Communications, 2025

Dysregulation of mitochondrial α-ketoglutarate dehydrogenase leads to elevated lipid peroxidation in CHCHD2-linked Parkinson's disease models.

Gao G et al.

Nature Communications, 2025

Investigation of mitochondrial phenotypes in motor neurons derived by direct conversion of fibroblasts from familial ALS subjects.

Woo E et al.

Biorxiv : the Preprint Server for Biology, 2025

A systematic review and functional in-silico analysis of genes and variants associated with amyotrophic lateral sclerosis.

Arreola-Aldape CA et al.

Frontiers in Neuroscience, 2025

40589786 (PubMed )
Supplement: Table_4.xlsx › ClinVar_filtered_variants

The Underestimated Role of Iron in Frontotemporal Dementia: A Narrative Review.

Ferretti S et al.

International Journal of Molecular Sciences, 2024

ALS Identified: two-year findings from a sponsored ALS genetic testing program.

Goutman SA et al.

Annals of Clinical and Translational Neurology, 2024

39044379 (PubMed )
Supplement: ACN3-11-2201-s003.xlsx › ClinGen_VariantClassification

Amyloid fibril structures link CHCHD10 and CHCHD2 to neurodegeneration.

Lv G et al.

Biorxiv : the Preprint Server for Biology, 2024

Synaptopathy: presynaptic convergence in frontotemporal dementia and amyotrophic lateral sclerosis.

Clayton EL et al.

Brain : a Journal of Neurology, 2024

Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS.

Chatterjee M et al.

Nature Medicine, 2024

38890531 (PubMed )
Supplement: 41591_2024_2937_MOESM3_ESM.pdf

CHCHD10 mutations induce tissue-specific mitochondrial DNA deletions with a distinct signature.

Shammas MK et al.

Human Molecular Genetics, 2023

Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion.

Liu T et al.

Cells, 2023

Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis.

Genin EC et al.

Genes, 2023

Genetic variability in sporadic amyotrophic lateral sclerosis.

Van Daele SH et al.

Brain : a Journal of Neurology, 2023

37043475 (PubMed )
Supplement: awad120_supplementary_data.zip › brain-2022-02191-File008.xlsx › suppl_table_7_VUS

Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy.

Bagyinszky E et al.

Cells, 2023

Effects of the Jokela type of spinal muscular atrophy-related G66V mutation on the structural ensemble characteristics of CHCHD10.

Alici H et al.

Proteins, 2023

CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.

Shammas MK et al.

Biochemical Society Transactions, 2023

Loss of mitochondrial Chchd10 or Chchd2 in zebrafish leads to an ALS-like phenotype and Complex I deficiency independent of the mitochondrial integrated stress response.

Petel Légaré V et al.

Developmental Neurobiology, 2023

Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic Variants.

McCann EP et al.

Journal of Neuromuscular Diseases, 2023

37638449 (PubMed )
Supplement: jnd-10-jnd230148-s001.xlsx › variant_list

Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Eck RJ et al.

Frontiers in Neuroscience, 2023

OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathy.

Shammas MK et al.

The Journal of Clinical Investigation, 2022

Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10.

Liu T et al.

Acta Neuropathologica Communications, 2022

Modelling amyotrophic lateral sclerosis in rodents.

Todd TW et al.

Nature Reviews. Neuroscience, 2022

Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship.

Candelise N et al.

Metabolites, 2022

CHCHD2 and CHCHD10: Future therapeutic targets in cognitive disorder and motor neuron disorder.

Jiang T et al.

Frontiers in Neuroscience, 2022

Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10-what distinguishes the two?

Ikeda A et al.

Frontiers in Cell and Developmental Biology, 2022

Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives.

Bonifacino T et al.

International Journal of Molecular Sciences, 2021

Genetics of frontotemporal dementia in China.

Jiang Y et al.

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2021

Multi-OMICS study of a CHCHD10 variant causing ALS demonstrates metabolic rewiring and activation of endoplasmic reticulum and mitochondrial unfolded protein responses.

Straub IR et al.

Human Molecular Genetics, 2021

TDP-43 and PINK1 mediate CHCHD10S59L mutation-induced defects in Drosophila and in vitro.

Baek M et al.

Nature Communications, 2021

Early death of ALS-linked CHCHD10-R15L transgenic mice with central nervous system, skeletal muscle, and cardiac pathology.

Ryan ÉB et al.

Iscience, 2021

Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.

Kee TR et al.

Frontiers in Aging Neuroscience, 2021

Mitochondria Dysfunction in Frontotemporal Dementia/Amyotrophic Lateral Sclerosis: Lessons From Drosophila Models.

Anoar S et al.

Frontiers in Neuroscience, 2021

CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.

Liu T et al.

Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2020

Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.

Zhou W et al.

The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry, 2020

Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.

McCann EP et al.

Journal of Neurology, Neurosurgery, and Psychiatry, 2020

Neuropathologic description of CHCHD10 mutated amyotrophic lateral sclerosis.

Keith JL et al.

Neurology. Genetics, 2020

Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.

Ranganathan R et al.

Frontiers in Neuroscience, 2020

1–50 of 97 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."